Cited by 980Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsExtracellular vesicles in disease

The DOI matches its Crossref record; 160 of the 162 references it cites were found in a registry or an index.

Targeting drugs to tumours using cell membrane-coated nanoparticles

Fang, Ronnie H., Gao, Weiwei, Zhang, Liangfang·2023·Nature Reviews Clinical Oncology

Open this paper in CoChat — free account

Abstract

Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-specific nature, causing harm to non-malignant tissues. Over the past several decades, nanomedicine researchers have sought to address this challenge by developing nanoscale platforms capable of more precisely delivering drug payloads. Cell membrane-coated nanoparticles (CNPs) are an emerging class of nanocarriers that have demonstrated considerable promise for biomedical applications. Consisting of a synthetic nanoparticulate core camouflaged by a layer of naturally derived cell membranes, CNPs are adept at operating within complex biological environments; depending on the type of cell membrane utilized, the resulting biomimetic nanoformulation is conferred with several properties typically associated with the source cell, including improved biocompatibility, immune evasion and tumour targeting. In comparison with traditional functionalization approaches, cell membrane coating provides a streamlined method for creating multifunctional and multi-antigenic nanoparticles. In this Review, we discuss the history and development of CNPs as well as how these platforms have been used for cancer therapy. The application of CNPs for drug delivery, phototherapy and immunotherapy will be described in detail. Translational efforts are currently under way and further research to address key areas of need will ultimately be required to facilitate the successful clinical adoption of CNPs.

Integrity signals

Registry

Crossref · 10.1038/s41571-022-00699-x

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodríguez-Torres, M. D. P., Acosta‐Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 7,038
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523

Show all 162 references

Research works printed but not linked: 1

McCarthy, E. F. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop. J. 26, 154–158 (2006).

Sorted by citations

Items 901–975 of 975

Functional matrix vesicle replacement partially restores chemo-mechanical coupling in the aged bone niche
Zhang, L., Wei, X., Zhang, K., Ding, F., Guo, Z., Zou, B., He, W., & Liu, W. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102923
Self-citation
Dual-Responsive Nanozyme Reactor Based on Hollow MnO2 on Upconversion Nanoparticles for Targeted Hepatocellular Carcinoma Therapy
Li, H., Fan, J., Liao, J., et al. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c01731
Latest advances in nanodrug delivery systems for modulating the immune microenvironment in triple-negative breast cancer
Dong, X., Cui, F., Wang, L., WU, M., Liu, Y., Gao, L., Xie, J., Lin, X., Sun, J., Zhou, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793737 · Cited by 2
Tumor Microenvironment-Responsive Biomimetic Self-Assembled Nanomedicine for Precision Combination Therapy against Triple-Negative Breast Cancer
Liu, Q., Tao, X. Y., Luo, Y., et al. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00693
A genetically engineered biomimetic nanomedicine with radio-taxis and CD47 blockade for precision tumor radio-immunotherapy
Zhao, X., Hu, Z., Xu, Q., Zou, J., Huo, J., Yang, Y., Yang, J., & Zhang, M. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179697
From barrier to guide: Exploiting disease-specific hemodynamics for enhanced nanodrug targeting in cardiovascular diseases
Wang, Z., Chen, X., Li, Y., Zhai, S., Guan, Z., & Zhang, W. (2026) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2026.100135
Enhancing Pancreatic Ductal Adenocarcinoma Immunotherapy under Stress through Sympathetic Nerve–T cell Interaction Blockade via Co-delivery of β-Blockers and aTIM-3 with Ultrasound-Responsive Bionic Nanoparticles
Li, W., Zhang, L., Li, T. C., Yun, Z., Ge, M., 滕步伟, Feng, T., Miao, M., Dai, Y., Li, K. R., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c11946
Self-citation
Cell Membrane-Modified Lipid Nanoparticle Enhanced Glioblastoma Immunotherapy via Metabolism Reprogramming and Pyroptosis Induction
Zhao, P., Tian, Y., Yuan, W., Bai, Y., Zhu, Y. C., Wang, L., Wu, R., Han, F., & Fan, T. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070901
HPV-driven metabolic reprogramming promotes T cell exhaustion: targeting immunometabolic barriers with natural products
Wei, L., Menghui, H., Zhang, D. J., Wang, X. G., Chu, X., Guangyi, 马. M., & Jing, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892919
Stimuli-Responsive “Smart” Nanomaterials in Oncology
Ullah, I., Raheem, H., Bashir, I., et al. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-9848-8.ch006
De novo design strategies of nanomedicines for antigen-specific immune tolerance modulation
Xi, Y., Ming, W., Mu, Q., Liu, G., & Liu, C. (2026) · Biomedical Technology · doi:10.1016/j.bmt.2026.100165
Bioinspired Macrophage‐Camouflaged Oxygen‐Self‐Supplying Nanoplatform for Precision Synergistic Ablation of Breast Cancer
Sun, Y., Gao, X., Gao, J., Chang, J., Tan, X., Yu, Y., Lu, Y., & Huo, D. (2026) · IET Nanobiotechnology · doi:10.1049/nbt2/4933996
Homologous Fe3+/Al3+-Baicalin nanoplatform remodel the tumor microenvironment for triple-negative breast cancer via synergistic ferroptosis and immunogenic cell death
Xia, F., Li, Z., Liang, S., et al. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116715
Programmable three‐state nanoreactor for spatiotemporally controlled tumor therapy
Lu, G., Ye, P., Li, X., et al. (2026) · BMEMat · doi:10.1002/bmm2.70098
Engineered tumor cell membrane-coated manganese-amplified STING nanoagonist potentiates PD-L1 blockade immunotherapy in non-small cell lung cancer
Guo, Y., Feng, S., Wang, K., Shao, J., Wang, R., & Lv, G. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116047
Inhalable HUCMSC-Lipo biomimetic formulation inhibits fibroblast activation in mouse and non-human primate pulmonary fibrosis models
Zhao, F., Sun, Y., Wang, H., Hou, D., Zhang, R., Xia, W., 张永臣, Li, L., Zhao, X., Wang, K., et al. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.08.013
Synchronous Reactive Oxygen Species Scavenging and Immunomodulation for Autoimmune Uveitis Therapy by a Mannosylated Biomimetic Nanocloak
Shu, J., Ling, D., Li, S., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c06477
Biomimetic Cancer Cell Membrane-Coated Polymeric Nanogels as a Therapeutic Vaccine for Synergistic Photothermo-Chemo-Immunotherapy of Nasopharyngeal Carcinoma
Wen, S., Huang, Y., Xiao, X., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c11261
Chondrocyte membrane-camouflaged selenium nanoplatform with dual targeting for mitochondrial restoration and osteoarthritis therapy
Zhang, Z., Du, Q., Zhu, Z., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115257
Nanomedicine for targeting crosstalk between nerves and cancer
Yu, X., Xiang, G., Wang, H., Li, X., Huang, H., Song, S., Xi, Q., Zhao, J., & Liu, F. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115269
Logic-gated nanoregulators: A paradigm shift from drug delivery to pre-programmed multi-target immunotherapy
Wu, Y., Tang, F., Lee, J., Liang, Y., Zengin, G., Zhang, Q., Sun, W., & Li, M. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124551
Intranasal delivery of engineered macrophage-membrane-coated nanoparticles with enhanced Dectin-1 expression for targeted therapy of cryptococcal meningitis
Liu, C., Geng, F., Liu, Y., Zhu, H., Shi, X., Lu, W., & Wei, G. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124559 · Cited by 1
Biomimetic Nanocarriers Based on Cell Membranes for Precision Drug Delivery: Advances, Applications, and Translational Challenges
Mahmoudian, F., Ahmari, A., Shamlou, S., Adibhesami, G., Aboutalebi, F., Garshasbi, S., Fattahi, F., & Kiani, J. (2026) · BioNanoScience · doi:10.1007/s12668-026-02801-4
Nanoconfined biomineralization enables albumin nanocages for tumor-penetrating and cathepsin B-triggered cancer therapy
Rehman, A., Chen, Y., Li, M., et al. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103158
Cell Membrane Biophysics as a Therapeutic Interface for Nanomedicine: From Disease-Associated Remodeling to Translational Qualification
Yin, Y., Fan, D., An, L., Liu, Y., & Liu, Y. (2026) · Cells · doi:10.3390/cells15171525
Bio‐Engineered Fungal‐MOF Nanoplatform Synergizes Macrophage Polarization and Checkpoint Blockade for Potent Melanoma Immunotherapy
Li, X., Guo, J., Meng, T., Yu, N., Mai, Y., Yang, J., & Zuo, W. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71650
Micro/nanoplatforms for modulating programmed cell death and tumor inflammation
Wu, X., Qu, H., & Wu, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36649-9.00005-0
Development of a drug delivery vehicle protein exhibiting high binding affinity and low leakage of the anti-cancer drug SN-38
Nakatsuji, M., Muroya, H., Okubo, R., Teraoka, Y., Yamada, M., Nishide, K., Yoshida, H., Furuta, K., Koyama, R., Kida, T., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154313
Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy
Kanbur, E., & Aydin, Ö. F. (2026) · Biogerontology · doi:10.1007/s10522-026-10489-y
Nanovaccine platforms for cancer immunotherapy from ex vivo engineering to in situ antigen capture strategies
Liang, H., Hu, R., Lu, B., Zhang, J., Yang, J., & Zhou, Z. (2026) · Nanoscale · doi:10.1039/d6nr02315k
CXCR2-engineered biomimetic prodrug nanoplatform restores STING signaling and enhances anti-glioma immunity
Bi, Q., Zhang, H., Ma, Z., Wang, Z., Zhu, H., Ali, K., Sun, X., Zhu, X., Wang, H., Zhao, Q., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181445
Cell Membrane-Coated Biomimetic Nanocarriers for Plaque-Targeted Atherosclerosis Therapy: Molecular Mechanisms, Inflammatory Microenvironments, and Translational Challenges
Zhang, R., Yuan, X., Sun, J., & Wei, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177718
NQO1‑activated self‑reinforcing bimetallic nanoplatform triggers ferroptosis and cuproptosis for osteosarcoma therapy
Zhang, Y., Bai, Q., Zhong, Y., Guo, X., Wang, S., Li, W., & Li, M. C. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116120
Recent advances and prospects in smart optical nanoprobes for precision detection of liver diseases
Zhang, Y., Chen, X., Wang, X., Zhang, J., & Liang, X. (2026) · Chemical Communications · doi:10.1039/d6cc04229e
Self-oxygenating nanoreactors enable effective low-dose X-ray photodynamic immunotherapy against refractory tumors
Yu, H., Liu, J., Wang, J., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124597
A Locally Injectable, pH/ROS-Responsive Hydrogel Platform for Combination Therapy of Cervical Cancer with Anti-Fibrotic and Chemotherapeutic Agents
Chen, Q., Yang, H., Pei, M., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091115
Temozolomide resistance in glioblastoma: Multidimensional networks, core signaling hubs, and targeted therapeutic strategies
Qin, Y., Zhao, Y., Li, B., Zhu, K., Jiang, T., Li, N., & 姜同翠 (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120221
Nanoparticle-Based Targeted Drug-Delivery Systems for Cardiomyopathy: Mechanisms and Therapeutic Advances
Liang, B., Zhang, T., Tang, S., Zhou, X., Xie, S., Jia, Z., Lin, H., Luo, G., & Lin, B. (2026) · Molecules · doi:10.3390/molecules31173137
Bufalin-Loaded Multifunctional Nanodrugs for Cancer Therapy: Mechanisms, Delivery Strategies, and Translational Perspectives
Yang, Y., Zeng, X., Hu, Y., Su, Y., Li, C., Lv, F., Zhao, K., & Hu, J. (2026) · Biomolecules · doi:10.3390/biom16091297
Precision immunomodulation of viral myocarditis: a spatiotemporal intervention paradigm based on smart biomaterials
Dai, Y., & Han, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1939896
Engineering nanomaterials for nanomedicine evolution: Progress, trends and translational challenges
Muhammad, S., Nabeel, M. I., Hameed, A., Joseph, C. G., Seemab, R., Ahmad, M., He, M., Zhao, Y., & Wang, J. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.103307
Advances in Organic Aggregates for Biomedical Phototheranostics
Fu, B., Peng, Y., & Cai, T. (2026) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70077
Research progress of NIR-II probes in metastatic tumor invasion
Pan, W., Xu, M., Gao, F., Rafiq, M., Zou, J., Ahmad, A., Haider, W., Cong, H., & Yu, B. (2026) · Sustainable materials and technologies · doi:10.1016/j.susmat.2026.e02241
CircLAMA5 traps Sam68 in the cytoplasm to regulate alternative splicing and drive sunitinib resistance in ccRCC
Xu, Z., Lu, H., Lu, Z., Wang, R., Zhu, Z., Ding, Y., Li, Y., Lu, Y., Li, F., Luo, W., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03981-9
Multifunctional nucleic acid-based therapy in fibrosis-related diseases
Cheng, J., Zhou, M., Guo, Y., Yang, Y., Lv, W., Renzeng, Y. A. N. G., Xie, Y., Jiang, Y., Yao, L., Qi, C., et al. (2026) · Science China Chemistry · doi:10.1007/s11426-025-3231-6
Mitochondria–Neutrophil Hybrid Membrane Nanovesicles for Photo-Driven Calcium Overload and Suppression of Phototherapy-Evoked Inflammation and Metastasis
Zhu, H., Bian, X., Yuan, Y., et al. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101202
Nanotherapeutic delivery systems in bacterial pneumonia: targeting, responsiveness, and immune modulation toward precision therapy
Krishnamoorthi, R., Wang, Y., Lin, C.-Y., Alalaiwe, A. S., & Fang, J. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00829-y
Smart drug delivery systems for immunotherapeutic agents: focus on biological/biogenic platform-based intelligent delivery in cancer immunotherapy
Abbasi, P., AfsharManesh, A., Rezaei, S., Mozdi, M., Shakeri, P., Nasab, N. K., Zaeifi, D., Jamialahmadi, K., & Oskuee, R. K. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02222-6
Shape-dependent transmembrane transport of mesenchymal stem cell membrane-coated mesoporous silica nanoparticles enhances anti-glioma therapy
Gong, Y., Fang, H., Li, X., He, S., Ding, Z., Xu, Y., Zhuang, T., Li, J., Zhao, W., Liu, H., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103703
Smart nanodelivery systems targeting tumor-associated macrophage reprogramming to potentiate cancer immunotherapy: pharmacological mechanisms, delivery strategies and translational perspectives
Sun, X., Chu, C., & Wang, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1919263
Bioinspired and biomimetic nanomaterials for advancing nanomedicine
Vișan, A. I., Anghel, S., Neguț, I., & Hapenciuc, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45321-2.00005-9
Macrophage membrane camouflaged puerarin and probucol co-assembled nanoparticles for targeted anti-atherosclerosis therapyPreprint
Gao, Y., Bai, Y., Zeng, J., Wang, Y., Zhang, Y., Jia, M., Guo, Y., Qiu, J., Li, Y., Fu, L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10939219/v1
Single-Particle STORM Imaging Quantifies Coating Heterogeneity Among Cell Membrane-Coated NanoparticlesPreprint
Blauser-Wilson, J., Zareein, A., Puth, S., Jadhav, S. S., Chen, R., Hernandez, A. M., Joseph, A. A., Zeng, J., Hougland, J. L., & Wu, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.755175
Zona pellucida-inspired smart viral vectors: a biomimetic platform for multi-modal immune evasion and triple-stimuli responsive gene delivery
Xu, Z., Luo, X., Li, Y., Qian, J., & Xu, G. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1949512
The future of brain tumor treatment: integrating platelet-based liquid biopsy, advanced drug delivery systems, and eicosanoid inhibition
Berardino, S. D., Zarà, M., Ahfaz, H. A., Tacconelli, S., & Patrignani, P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1956969
Iterative Optimization of Photoactivatable BRD4 Degraders for Aging‐Amplified Immunotherapy in Patient‐Derived Lung Cancer Organoids
Yang, J., Wang, F., Li, S., Xiong, K., Liu, T., Chen, Y., & Chao, H. (2026) · Angewandte Chemie · doi:10.1002/ange.2645239
Iterative Optimization of Photoactivatable BRD4 Degraders for Aging‐Amplified Immunotherapy in Patient‐Derived Lung Cancer Organoids
Yang, J., Wang, F., Li, S., Xiong, K., Liu, T., Chen, Y., & Chao, H. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.2645239
Nanocarrier-mediated immune microenvironment remodelling in osteosarcoma
Fu, J., Bi, Z., Wei, R., Lv, S., & Guo, Y. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103181
Nanoparticle-Based Drug Delivery Systems for Anticancer Therapy: Microenvironment-Driven Strategies, Advances, and Challenges
Ban, M., Zhao, S., Liu, Z., & Zhao, L. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101273
Advances and projects of immunomodulatory biomaterials used for immunotherapy
Frumento, D., & Patra, N. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00296-3
Iron oxide nanoparticles for hepatocellular carcinoma theranostics: From nanoplatform design to clinical translation
Cheng, R. (2026) · Journal of Biomaterials Applications · doi:10.1177/08853282261496086
Bioengineered Hybrid Nanovesicles Modulate the Immune Microenvironment with Targeted Drug Delivery for Esophageal Squamous Cell Carcinoma Therapy
Xie, F., Feng, L., Wang, Y., Huang, C., Wang, C., Luo, C., Zhang, L., Sun, C., & Wang, Q. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c14588
Self-citation
Chimeric antigen receptor-engineered tumor-infiltrating lymphocyte membrane-coated nanoparticles exhibit enhanced antitumor efficacy against Huh7 hepatocellular carcinoma with reduced toxicity
Yan, J. J., Meng, L. W., Zeng, Y. Y., Zhang, M. Y., Liu, Q. Q., Zhan, M. J., Yu, H., Liu, Q., Chen, Y., Liao, J., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.182999
Cell membrane coated nanoparticles for the diagnosis and treatment of atherosclerosis
Zhao, Q., & Yu, C. (2026) · Materials Advances · doi:10.1039/d6ma00859c
Biogenic metallic nanoparticles as multifunctional theranostic platforms for targeted drug delivery and imaging
Tiwari, S., Mago, P., & Mehra, V. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100833
Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy
Wang, T., Wang, L., Kang, X., Jiang, J., Yuan, B., Zhang, L., Yu, X., Chen, T., Li, X., Zhang, Y., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115460
Self-citation
Well-educated macrophage membrane-camouflaged piezoelectric nanosystem reprograms immune microenvironment for bone regenerationPreprint
Qian, X., Ji, X., Zhang, Y., Jiang, L., Chen, L., Wang, Y., Li, W., Li, C., Yang, P., Song, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11096851/v1
Engineering Cell Membrane-Coated Nanoparticles: A Route for Enhanced Therapeutic Efficacy
Yang, H., Zhu, X., Wang, Y., Yang, J., & Feng, X. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c16232
Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges
Jacob, S., Varkey, N. R., Rao, R., Shinu, P., & Khanam, R. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101314
Engineering Biomimetic Nanoparticle to induce Cuproptosis, Gas Therapy and Glycolysis Blockade for Melanoma Treatment
Li, M., Liang, J., Ding, L., et al. (2026) · ChemPhysMater · doi:10.1016/j.chphma.2026.10.001
Triphenylamine-based AIEgens: Molecular design, mechanisms, and applications in organelle-targeted imaging and phototherapy
Chen, C., Ji, J., Wu, P., Yang, Y., Zhao, F., Kwok, R. T. K., Sun, J., 陈晓英, Ma, H., Lam, J. W. Y., et al. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218699
Mn-La-based biomimetic nanoreactor-driven targeted induction of ferroptosis and apoptosis for carfilzomib therapy potentiation in multiple myeloma
Li, M., Yao, J., Lin, Z., Zha, J., Huang, W., Wang, A., Ma, M., 罗芳洪, 罗芳洪, Wang, P., et al. (2026) · Journal of Rare Earths · doi:10.1016/j.jre.2026.10.019
Cartilage-targeted reprogramming of linoleic acid metabolism alleviates osteoarthritis by suppressing ferroptosis
Ying, C., Lin, C., He, G., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.183447
Pharmacologically programmed tolerogenic dendritic cell membrane-coated nanoparticles for CCR7-dependent lymphoid organ targeting in transplantation
Wu, Z., Zhou, K., Wang, N., Yan, J., Lu, Z., Fu, Y., Tong, X., Xiang, Y., Shi, Y., Yang, S., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124719
miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Networks to Nanocarrier-Based Delivery for Solid Tumor Therapy
Leng, T., Lv, Y., Rao, C., Zhu, X., Jiang, Y., Hu, S., Rao, C., & Ma, X. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00683-1

Authors: Fang, R. H., Gao, W., & Zhang, L.
Affiliations: University of California San Diego (US)
Corresponding author: Zhang, Liangfang
ORCID: Fang, Ronnie H.
Gao, Weiwei
Zhang, Liangfang
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2022-10-28
Volume: 20
Issue: 1
Pages: 33-48
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/s41571-022-00699-x
OpenAlex: W4307475977
Semantic Scholar: aad18fe7d6405872bceb0dd4451cf81880d894d6
Cited by: 980
References: 162
Citations by year: 2026: 249 · 2025: 320 · 2024: 281 · 2023: 129 · 2022: 1
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA200574)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: cell membrane-coated nanoparticles, anticancer drug delivery, tumor targeting, biomimetic nanocarriers, immune evasion, phototherapy, cancer immunotherapy, nanoparticle biocompatibility
MeSH terms: Cell Membrane, Pharmaceutical Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting drugs to tumours using cell membrane-coated nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks